InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,726.74
(
-0.11%
)
US TECH 100
19,457.20
(
0.22%
)
Dow Jones
41,981.82
(
-0.54%
)
Brent Oil
73.47
(
-1.47%
)
Bitcoin
63,469.74
(
-1.24%
)
Post# of 659267
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Monksdream

Send PM Follow Ignore
Followers 273
Posts 55242
Boards Moderated 24
Alias Born 08/29/2007

Monksdream

Member Level

Re: None

Wednesday, 06/16/2021 8:47:37 AM

Wednesday, June 16, 2021 8:47:37 AM

Post# of 659267
Will it have legs later this morning?

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces the advancement of its targeted oncology therapeutics into several novel immunotherapy cell lines: Bria-Pros™ for prostate cancer, Bria-Mel™ for melanoma, and Bria-Lung™ for lung cancer.

I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up